Growth Hormone and Prolactin Responses to Thyrotropin- Releasing Hormone in Patients with Severe Liver Disease
- 1 July 1977
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 45 (1) , 134-140
- https://doi.org/10.1210/jcem-45-1-134
Abstract
Thyrotropin-releasing hormone (TRH) was administered i.v. to 10 patients with severe liver disease and 10 control subjects. Injection of 400 .mu.g TRH as a bolus induced in 7 out of 10 patients a clear-cut GH [growth hormone] rise (.gtoreq. 10 ng/ml) occurring 15-120 min after the injection, and no effect on GH levels in controls. Mean baseline GH levels were higher in patients than in controls. An exaggerated and sustained PRL [prolactin] rise was present after TRH in the subjects with liver disease, whose mean baseline plasma PRL levels were within normal range.This publication has 5 references indexed in Scilit:
- On the role of dopamine in the pathophysiology of anorexia nervosaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1976
- Stimulation of Growth Hormone Release by Thyrotropin-Releasing Hormone in the Hypophysectomized Rat Bearing an Ectopic PituitaryEndocrinology, 1976
- 5-Hydroxytryptamine in the Hind-Brain of Depressive SuicidesThe British Journal of Psychiatry, 1967
- Paradoxical Hypersecretion of Growth Hormone in Response to GlucoseJournal of Clinical Endocrinology & Metabolism, 1966
- STUDIES ON HUMAN GROWTH HORMONE. I. A RADIO-IMMUNOASSAY FOR HUMAN GROWTH HORMONE*Journal of Clinical Investigation, 1962